Company Filing History:
Years Active: 2023
Title: Matthew Lam: Innovator in Pharmaceutical Compositions
Introduction: Matthew Lam is a distinguished inventor based in Sussex, GB, known for his contributions to the field of pharmaceuticals. With a keen focus on improving medication formulation processes, he holds a patent that showcases his innovative approach to pharmaceutical methods.
Latest Patents: Matthew's notable patent is titled "Pharmaceutical methods and compositions." This patent outlines a method of producing a pharmaceutical composition through several key steps. Firstly, an active pharmaceutical ingredient (API) is dissolved in a liquid vehicle to create a liquid medicament. Next, this medicament is combined with a pharmaceutical carrier. The innovative aspect continues as the composition, which now includes both the liquid medicament and pharmaceutical carrier, is treated with a pharmaceutical coating material to form a liqui-mass composition. Finally, the liqui-mass composition is pelletized to yield the final pharmaceutical composition.
Career Highlights: Matthew Lam is currently employed at the University of Sussex, where he leverages his expertise in pharmaceutical sciences. His work not only reflects his innovative capabilities but also contributes to the academic and practical realms of medication development, benefiting patients and the healthcare industry alike.
Collaborations: In his pursuit of innovation, Matthew collaborates with Ali Nokhodchi, a fellow researcher. Their partnership emphasizes the importance of teamwork in the research community, driving advancements in pharmaceutical methodologies and compositions.
Conclusion: Matthew Lam's innovative contributions to pharmaceutical compositions illustrate the transformative potential of dedicated research and collaboration. Holding a patent for a method that enhances drug formulation, his work at the University of Sussex marks a significant stride in the pharmaceutical industry, promising better solutions for medication delivery and efficacy.